$MTEX
Mannatech Inc Stock $mtex

$mtex Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000105635824000042 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$27.70M	$29.40M	$32.69M
YoY Change	-15.03%	-13.78%	-4.78%
Cost Of Revenue	$6.363M	$6.296M	$8.048M
YoY Change	-9.15%	-15.07%	-24.31%
Gross Profit	$21.38M	$23.10M	$24.65M
YoY Change	-16.46%	-13.5%	3.98%
Gross Profit Margin	77.17%	78.56%	75.38%
Selling, General & Admin	$22.52M	$21.86M	$41.38M
YoY Change	8.68%	9.45%	97.18%
% of Gross Profit	105.35%	94.65%	167.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$400.0K	$416.0K	$408.0K
YoY Change	3.36%	7.49%	46.76%
% of Gross Profit	1.87%	1.8%	1.66%
Operating Expenses	$22.52M	$22.28M	$25.54M
YoY Change	-15.16%	-14.28%	-3.08%
Operating Profit	-$1.143M	$820.0K	-$895.0K
YoY Change	19.81%	15.01%	-66.23%
Interest Expense	$995.0K	$918.0K	-$963.0K
YoY Change	423.68%	3725.0%	-713.38%
% of Operating Profit		111.95%
Other Income/Expense, Net	$1.120M	$871.0K	-$3.000K
YoY Change	646.67%	161.56%	-99.48%
Pretax Income	-$128.0K	$1.709M	-$1.861M
YoY Change	-84.28%	59.72%	-39.36%
Income Tax	$496.0K	$529.0K	-$105.0K
% Of Pretax Income		30.95%
Net Earnings	-$624.0K	$1.180M	-$1.756M
YoY Change	-43.53%	95.36%	-73.02%
Net Earnings / Revenue	-2.25%	4.01%	-5.37%
Basic Earnings Per Share	-$0.33	$0.63
Diluted Earnings Per Share	-$0.33	$0.63	-$0.94
COMMON SHARES
Basic Shares Outstanding	1.885M shares	1.885M shares	1.860M shares
Diluted Shares Outstanding	1.885M shares	1.884M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.196M	$7.911M	$7.731M
YoY Change	-1.9%	-42.18%	-43.88%
Cash & Equivalents	$9.200M	$7.911M	$7.731M
Short-Term Investments
Other Short-Term Assets	$5.062M	$5.920M	$4.842M
YoY Change	-35.1%	-26.91%	-16.65%
Inventory	$13.20M	$13.70M	$14.54M
Prepaid Expenses
Receivables	$99.00K	$320.0K	$91.00K
Other Receivables	$416.0K	$450.0K	$465.0K
Total Short-Term Assets	$27.93M	$28.28M	$27.66M
YoY Change	-10.64%	-22.42%	-20.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.110M	$6.873M	$7.462M
YoY Change	-30.9%	47.68%	96.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.511M	$6.711M	$5.880M
YoY Change	-55.18%	-16.96%	-30.0%
Total Long-Term Assets	$11.99M	$12.78M	$13.54M
YoY Change	-15.27%	-10.42%	-4.47%
TOTAL ASSETS
Total Short-Term Assets	$27.93M	$28.28M	$27.66M
Total Long-Term Assets	$11.99M	$12.78M	$13.54M
Total Assets	$39.92M	$41.06M	$41.21M
YoY Change	-12.08%	-19.05%	-16.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.454M	$4.882M	$4.010M
YoY Change	-40.7%	-13.79%	-8.05%
Accrued Expenses	$5.965M	$5.899M	$7.500M
YoY Change	-13.55%	-15.73%	-0.13%
Deferred Revenue		$4.235M	$4.786M
YoY Change		-23.0%	-6.16%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$636.0K	$790.0K	$509.0K
YoY Change	-7.15%	-8.99%	57.1%
Total Short-Term Liabilities	$23.96M	$26.15M	$25.78M
YoY Change	-15.16%	-16.34%	-13.6%
LONG-TERM LIABILITIES
Long-Term Debt	$4.420M	$888.0K	$956.0K
YoY Change	296.41%	-14.62%	986.36%
Other Long-Term Liabilities	$1.360M	$3.578M	$3.986M
YoY Change	-69.09%	-22.22%	-20.28%
Total Long-Term Liabilities	$1.360M	$3.578M	$4.942M
YoY Change	-69.09%	-22.22%	-1.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.96M	$26.15M	$25.78M
Total Long-Term Liabilities	$1.360M	$3.578M	$4.942M
Total Liabilities	$31.72M	$30.61M	$30.72M
YoY Change	-6.05%	-16.97%	-12.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$745.0K	-$121.0K	-$1.301M
YoY Change	-270.48%	-106.32%	-177.16%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$19.94M	$19.94M	$20.51M
YoY Change	-2.42%	-1.95%	-0.82%
Treasury Stock Shares
Shareholders Equity	$8.199M	$10.45M	$10.48M
YoY Change
Total Liabilities & Shareholders Equity	$39.92M	$41.06M	$41.21M
YoY Change	-12.08%	-19.05%	-16.13%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$624.0K	$1.180M	-$1.756M
YoY Change	-43.53%	95.36%	-73.02%
Depreciation, Depletion And Amortization	$400.0K	$416.0K	$408.0K
YoY Change	3.36%	7.49%	46.76%
Cash From Operating Activities	-$2.666M	$1.874M	-$1.320M
YoY Change	-0.78%	38.71%	-56.83%
INVESTING ACTIVITIES
Capital Expenditures	$82.00K	$61.00K	$208.0K
YoY Change	-67.2%	-41.35%	19.54%
Acquisitions
YoY Change
Other Investing Activities			$1.000K
YoY Change
Cash From Investing Activities	-$82.00K	-$61.00K	-$207.0K
YoY Change	-67.2%	-41.35%	18.97%
FINANCING ACTIVITIES
Cash Dividend Paid		$0.00
YoY Change		-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.359M	-$250.0K	-273.0K
YoY Change	-565.24%	-55.2%	-73.16%
NET CHANGE
Cash From Operating Activities	-2.666M	$1.874M	-1.320M
Cash From Investing Activities	-82.00K	-$61.00K	-207.0K
Cash From Financing Activities	3.359M	-$250.0K	-273.0K
Net Change In Cash	611.0K	$155.0K	-1.800M
YoY Change	-116.7%	-246.23%	-57.64%
FREE CASH FLOW
Cash From Operating Activities	-$2.666M	$1.874M	-$1.320M
Capital Expenditures	$82.00K	$61.00K	$208.0K
Free Cash Flow	-$2.748M	$1.813M	-$1.528M
YoY Change	-6.44%	45.39%	-52.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	99000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2742857	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1884814	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	99000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2742857	shares
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	858043	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1860154	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	882703	shares
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2130000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	693000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	525000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	718000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4882000	usd
CY2024Q1	mtex	Commissions And Incentives Payable CommissionsAndIncentivesPayable	8419000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4010000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	240000	usd
CY2023Q4	mtex	Commissions And Incentives Payable CommissionsAndIncentivesPayable	8175000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1922000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1521000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4786000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3578000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	26147000	usd
CY2024Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	888000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25780000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	956000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29393000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32948000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34114000	usd
CY2024Q1	us-gaap	Assets Assets	41058000	usd
CY2024Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	265000	usd
CY2023Q4	us-gaap	Assets Assets	41206000	usd
CY2023Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	269000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4235000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3986000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	30613000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	30722000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33309000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1015000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	20509000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	10445000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10484000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41058000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41206000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1200000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1278000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	7413000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	23097000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	26701000	usd
CY2024Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	11685000	usd
CY2023Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	13558000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10176000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12043000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	22277000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	25988000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	820000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	713000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	871000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	333000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1709000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1070000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	529000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1884000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1872000	shares
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-251000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-195000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1860154	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10484000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	200000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14176000	usd
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	375000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	12808	shares
CY2022Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	223000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1873608	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13852000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	415000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	32000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-75000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	112000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1860154	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10484000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1301000	usd
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	200000	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	19936000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	6296000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	7413000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	23097000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	26701000	usd
CY2024Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	11685000	usd
CY2023Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	13558000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10176000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12043000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	22277000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	25988000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	820000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	713000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	871000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	333000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1709000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1070000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	529000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	466000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1884000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1884000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1884814	shares
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-251000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-195000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10445000	usd
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	375000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	12808	shares
CY2022Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	223000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2446000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	6296000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	7413000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	23097000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	26701000	usd
CY2024Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	11685000	usd
CY2023Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	13558000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10176000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12043000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	22277000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	25988000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	820000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	713000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	871000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	333000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1709000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1070000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	529000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	466000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1884000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1872000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1884000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1891000	shares
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-251000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-195000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1860154	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10484000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	200000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1858800	shares
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	375000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	12808	shares
CY2022Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	223000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1873608	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13852000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	6296000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	7413000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	23097000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	26701000	usd
CY2024Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	11685000	usd
CY2023Q1	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	13558000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10176000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12043000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	22277000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	25988000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	820000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	713000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	871000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	333000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1709000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1070000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	529000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	466000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1884000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1891000	shares
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-251000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-195000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	200000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1431000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1884814	shares
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10445000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1858800	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14176000	usd
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	375000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	12808	shares
CY2022Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	223000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-799000	usd
CY2024Q1	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	402000	usd
CY2023Q1	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	415000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	32000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	73000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-75000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2024Q1	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	402000	usd
CY2023Q1	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	415000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	32000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-75000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	112000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	212000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	234000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	437000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	154000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-15000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	26000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-824000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	667000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	909000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	504000	usd
CY2024Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-294000	usd
CY2023Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	49000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	158000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	123000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	872000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1302000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1085000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-701000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-408000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-451000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	401000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1301000	usd
CY2024Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	244000	usd
CY2023Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	992000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-551000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	398000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1874000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1351000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	375000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	250000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	194000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-558000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1408000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-795000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	155000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2023Q1	mtex	Operating Right Of Use Lease Liabilities Net OperatingRightOfUseLeaseLiabilitiesNet	415000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	32000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-75000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	112000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	212000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	234000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	437000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	154000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-15000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	26000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-824000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	667000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	909000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	504000	usd
CY2024Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-294000	usd
CY2023Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	49000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	158000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	123000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	872000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1302000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-701000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-408000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-451000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	401000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1301000	usd
CY2024Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	244000	usd
CY2023Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	992000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-551000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1874000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1351000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	375000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	250000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	194000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-558000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1408000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-795000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	155000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-106000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	73000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1895000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	23000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	112000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	212000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	234000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	437000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	154000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-15000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	26000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-824000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	667000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	909000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	504000	usd
CY2024Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-294000	usd
CY2023Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	49000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	158000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	123000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	872000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1302000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1085000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-701000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-408000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-451000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	401000	usd
CY2024Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	244000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-551000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1874000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1351000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	375000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	250000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	194000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-558000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1408000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-795000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	155000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-106000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	73000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1895000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	23000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	446000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	497000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	212000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	234000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	437000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	154000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-15000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	26000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-824000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	667000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	909000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	504000	usd
CY2024Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-294000	usd
CY2023Q1	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	49000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	158000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	123000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	872000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1302000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-701000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-408000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-451000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	401000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1301000	usd
CY2024Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	244000	usd
CY2023Q1	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	992000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-551000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1874000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1351000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	375000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	250000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	194000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-558000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1408000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	155000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-106000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	73000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1895000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	23000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	446000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	497000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	205000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	181000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	73000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1895000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	23000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	446000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	497000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	205000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	181000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1181000	usd
CY2024Q1	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The use of estimates is pervasive throughout the condensed consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the condensed consolidated financial statements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Organization and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7700000	usd
CY2024Q1	us-gaap	Credit Card Receivables CreditCardReceivables	1900000	usd
CY2023Q4	us-gaap	Credit Card Receivables CreditCardReceivables	1400000	usd
CY2024Q1	us-gaap	Due From Banks DueFromBanks	4000000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	3500000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1600000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1700000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	944000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	944000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	944000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	693000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	693000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	446000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	497000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	205000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	181000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1181000	usd
CY2024Q1	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The use of estimates is pervasive throughout the condensed consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the condensed consolidated financial statements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Organization and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7700000	usd
CY2024Q1	us-gaap	Credit Card Receivables CreditCardReceivables	1900000	usd
CY2023Q4	us-gaap	Credit Card Receivables CreditCardReceivables	1400000	usd
CY2024Q1	us-gaap	Due From Banks DueFromBanks	4000000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	3500000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1600000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1700000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7911000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7731000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13682000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13777000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	205000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	181000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1181000	usd
CY2024Q1	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The use of estimates is pervasive throughout the condensed consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the condensed consolidated financial statements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Organization and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7700000	usd
CY2024Q1	us-gaap	Credit Card Receivables CreditCardReceivables	1900000	usd
CY2023Q4	us-gaap	Credit Card Receivables CreditCardReceivables	1400000	usd
CY2024Q1	us-gaap	Due From Banks DueFromBanks	4000000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	3500000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1600000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1700000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7911000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7731000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13682000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13777000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1181000	usd
CY2024Q1	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The use of estimates is pervasive throughout the condensed consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the condensed consolidated financial statements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Organization and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7700000	usd
CY2024Q1	us-gaap	Credit Card Receivables CreditCardReceivables	1900000	usd
CY2023Q4	us-gaap	Credit Card Receivables CreditCardReceivables	1400000	usd
CY2024Q1	us-gaap	Due From Banks DueFromBanks	4000000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	3500000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1600000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1700000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7911000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7731000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13682000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13777000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	944000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	693000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	718000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	465000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	476000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7911000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7731000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13682000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13777000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	938000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	944000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	944000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	693000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	718000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	465000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	476000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	320000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	218000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1100000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1278000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	973000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-75000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	153000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1109000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3104000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3315000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	2121000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	2204000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	718000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	465000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	476000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9387000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	218000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	973000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-75000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	-3000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	153000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1109000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3104000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3315000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	2121000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	2204000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	1249000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	1310000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6711000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7066000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1772000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1707000	usd
CY2024Q1	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	112000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	718000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	465000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	476000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9542000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	320000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	218000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1100000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1278000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	973000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-75000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-17000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	-3000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	153000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1109000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3104000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3315000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	2121000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	2204000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	1249000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	1310000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6711000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7066000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1772000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15091000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15197000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	320000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	218000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1100000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1278000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-75000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-17000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	-3000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	153000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1109000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3104000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3315000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	2121000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	2204000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	1249000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	1310000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6711000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7066000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1772000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1707000	usd
CY2024Q1	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	112000	usd
CY2023Q4	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	861000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	39000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	38000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	181000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	1249000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	1310000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	237000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6711000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7066000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1772000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1707000	usd
CY2024Q1	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	112000	usd
CY2023Q4	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	861000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	39000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	38000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	181000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	201000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	506000	usd
CY2024Q1	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	573000	usd
CY2023Q4	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	515000	usd
CY2024Q1	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	123000	usd
CY2023Q4	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	131000	usd
CY2024Q1	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	312000	usd
CY2023Q4	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	291000	usd
CY2024Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2023Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	735000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	865000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1688000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1661000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5899000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6779000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	500000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.105
CY2024Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	2152000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	1938000	usd
CY2024Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	761000	usd
CY2023Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	896000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3056000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1707000	usd
CY2024Q1	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	112000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	39000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	38000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	181000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	506000	usd
CY2024Q1	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	573000	usd
CY2023Q4	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	515000	usd
CY2024Q1	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	123000	usd
CY2023Q4	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	131000	usd
CY2024Q1	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	312000	usd
CY2023Q4	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	291000	usd
CY2024Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2023Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	735000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	865000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1688000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1661000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5899000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6779000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	500000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	200000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.105
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2242000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2582000	usd
CY2024Q1	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	351000	usd
CY2023Q4	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	369000	usd
CY2024Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	793000	usd
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	822000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	192000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	213000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3578000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3986000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3748000	usd
CY2023Q1	us-gaap	Dividends Dividends	400000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	90000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	90000	usd
CY2023Q4	mtex	Noninventoryaccrualcurrent Noninventoryaccrualcurrent	861000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	39000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	38000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	181000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	201000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	506000	usd
CY2024Q1	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	573000	usd
CY2023Q4	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	515000	usd
CY2024Q1	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	123000	usd
CY2023Q4	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	131000	usd
CY2024Q1	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	312000	usd
CY2023Q4	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	291000	usd
CY2024Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2023Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	735000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	865000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1688000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1661000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5899000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6779000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	500000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	200000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.105
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2242000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2582000	usd
CY2024Q1	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	351000	usd
CY2023Q4	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	369000	usd
CY2024Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	793000	usd
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	822000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	192000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	213000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3578000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3986000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	858043	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	882703	shares
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	132000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	201000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	506000	usd
CY2024Q1	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	573000	usd
CY2023Q4	mtex	Accrued Customer Deposits And Sales Returns Current AccruedCustomerDepositsAndSalesReturnsCurrent	515000	usd
CY2024Q1	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	123000	usd
CY2023Q4	mtex	Accrued Travel Expenses Related To Corporate Events AccruedTravelExpensesRelatedToCorporateEvents	131000	usd
CY2024Q1	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	312000	usd
CY2023Q4	mtex	Accrued Shipping And Handling Costs AccruedShippingAndHandlingCosts	291000	usd
CY2024Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2023Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	3000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	735000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	865000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1688000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1661000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5899000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6779000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	500000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.105
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2242000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2582000	usd
CY2024Q1	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	351000	usd
CY2023Q4	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	369000	usd
CY2024Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	793000	usd
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	822000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	192000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	213000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3578000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3986000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3100000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2242000	usd
CY2024Q1	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	351000	usd
CY2023Q4	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	369000	usd
CY2024Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	793000	usd
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	822000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	192000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	213000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3578000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3986000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1100000	usd
CY2023Q4	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1400000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Associate Fees Amount RevenueRemainingPerformanceObligationAssociateFeesAmount	100000	usd
CY2023Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2130000	usd
CY2022Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2476000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1411000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1779000	usd
CY2024Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1117000	usd
CY2023Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1828000	usd
CY2023Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	2525000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	4786000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5106000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-3733000	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-3566000	usd
CY2024Q1	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	3182000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	4235000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	5504000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3700000	usd
CY2023Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3242000	usd
CY2022Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	4167000	usd
CY2024Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	718000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	770000	usd
CY2024Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2381000	usd
CY2023Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2483000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1100000	usd
CY2023Q4	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1400000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Associate Fees Amount RevenueRemainingPerformanceObligationAssociateFeesAmount	100000	usd
CY2023Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2130000	usd
CY2022Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2476000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1411000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1779000	usd
CY2024Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1117000	usd
CY2023Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1828000	usd
CY2024Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	1836000	usd
CY2023Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	2525000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	4786000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5106000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-3733000	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-3566000	usd
CY2024Q1	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	3182000	usd
CY2023Q1	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	3964000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	4235000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	5504000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3100000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3700000	usd
CY2023Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3242000	usd
CY2022Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	4167000	usd
CY2024Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	718000	usd
CY2024Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2381000	usd
CY2023Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2483000	usd
CY2024Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	2152000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	1938000	usd
CY2024Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	761000	usd
CY2023Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	896000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3056000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3748000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	858043	shares
CY2024Q1	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1100000	usd
CY2023Q4	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1400000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Associate Fees Amount RevenueRemainingPerformanceObligationAssociateFeesAmount	100000	usd
CY2023Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2130000	usd
CY2022Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2476000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1411000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1779000	usd
CY2024Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1117000	usd
CY2023Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1828000	usd
CY2024Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	1836000	usd
CY2023Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	2525000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	4786000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5106000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-3733000	usd
CY2023Q1	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	3964000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	4235000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	5504000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3100000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3700000	usd
CY2023Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3242000	usd
CY2022Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	4167000	usd
CY2024Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	718000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	770000	usd
CY2023Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2483000	usd
CY2024Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	2152000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	1938000	usd
CY2024Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	761000	usd
CY2023Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	896000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3748000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	858043	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	882703	shares
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	268000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	90000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1100000	usd
CY2023Q4	mtex	Revenue Remaining Performance Obligation Delivery Amount RevenueRemainingPerformanceObligationDeliveryAmount	1400000	usd
CY2024Q1	mtex	Revenue Remaining Performance Obligation Associate Fees Amount RevenueRemainingPerformanceObligationAssociateFeesAmount	100000	usd
CY2023Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2130000	usd
CY2022Q4	us-gaap	Deferred Sales Commission DeferredSalesCommission	2476000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1411000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1779000	usd
CY2024Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1117000	usd
CY2023Q1	mtex	Increase Decrease Deferred Commission IncreaseDecreaseDeferredCommission	1828000	usd
CY2024Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	1836000	usd
CY2023Q1	us-gaap	Deferred Sales Commission DeferredSalesCommission	2525000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	4786000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5106000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-3733000	usd
CY2024Q1	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	3182000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	4235000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	5504000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3100000	usd
CY2023Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3700000	usd
CY2022Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	4167000	usd
CY2024Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	718000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	770000	usd
CY2024Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2381000	usd
CY2023Q1	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	2483000	usd
CY2023Q1	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	1938000	usd
CY2024Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	761000	usd
CY2023Q1	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	896000	usd
CY2024Q1	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	3056000	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	59000	usd
CY2023Q1	mtex	Valuation Allowances And Reserves Charged To Cost And Expense Current Year Sales ValuationAllowancesAndReservesChargedToCostAndExpenseCurrentYearSales	266000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-244000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	882703	shares
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	59000	usd
CY2023Q1	mtex	Valuation Allowances And Reserves Charged To Cost And Expense Current Year Sales ValuationAllowancesAndReservesChargedToCostAndExpenseCurrentYearSales	266000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-244000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5068000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5104000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8611000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9431000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13679000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14535000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.436
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	59000	usd
CY2023Q1	mtex	Valuation Allowances And Reserves Charged To Cost And Expense Current Year Sales ValuationAllowancesAndReservesChargedToCostAndExpenseCurrentYearSales	266000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-244000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5068000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5104000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8611000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9431000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13679000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14535000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.436
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	59000	usd
CY2023Q1	mtex	Valuation Allowances And Reserves Charged To Cost And Expense Current Year Sales ValuationAllowancesAndReservesChargedToCostAndExpenseCurrentYearSales	266000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-244000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5068000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5104000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8611000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9431000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13679000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14535000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.436
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5068000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5104000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8611000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9431000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13679000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14535000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.436
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	882703	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
CY2024Q1	mtex	Average Share Price AverageSharePrice	8.84
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1880000	shares
CY2024Q1	mtex	Incremental Restricted Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements IncrementalRestrictedSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangements	8187	usd
CY2023Q1	mtex	Average Share Price AverageSharePrice	17.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1870000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18221	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86276	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1884000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1872000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1884000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	370000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	75621	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8187	shares
CY2024Q1	ecd	Award Grant Date Fair Value AwardGrantDateFairValue	100000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2024Q1	mtex	Average Share Price AverageSharePrice	8.84
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1880000	shares
CY2024Q1	mtex	Incremental Restricted Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements IncrementalRestrictedSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangements	8187	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	199824	shares
CY2023Q1	mtex	Average Share Price AverageSharePrice	17.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1870000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18221	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86276	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1872000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1884000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	370000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	75621	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8187	shares
CY2024Q1	ecd	Award Grant Date Fair Value AwardGrantDateFairValue	100000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	12808	shares
CY2024Q1	mtex	Average Share Price AverageSharePrice	8.84
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1880000	shares
CY2024Q1	mtex	Incremental Restricted Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements IncrementalRestrictedSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangements	8187	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	199824	shares
CY2023Q1	mtex	Average Share Price AverageSharePrice	17.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1870000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18221	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86276	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1872000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1884000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	370000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	75621	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8187	shares
CY2024Q1	ecd	Award Grant Date Fair Value AwardGrantDateFairValue	100000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	12808	shares
CY2024Q1	mtex	Average Share Price AverageSharePrice	8.84
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1880000	shares
CY2024Q1	mtex	Incremental Restricted Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements IncrementalRestrictedSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangements	8187	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	199824	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1870000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18221	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86276	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	604000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1884000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1872000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1884000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	370000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	75621	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8187	shares
CY2024Q1	ecd	Award Grant Date Fair Value AwardGrantDateFairValue	100000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	24660	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
CY2023Q1	us-gaap	Dividends Dividends	400000	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	LITIGATION<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Litigation in General</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary. The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</span></div>
CY2024Q1	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2023	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1200000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M28D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q1	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	4255000	usd
CY2023Q4	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	4551000	usd
CY2024Q1	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	5083000	usd
CY2023Q4	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	5468000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1367000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	248000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	99000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	1245000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	726000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	649000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	315000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
CY2023Q1	us-gaap	Dividends Dividends	400000	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	LITIGATION<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Litigation in General</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary. The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</span></div>
CY2024Q1	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2023	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1200000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M28D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q1	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	4255000	usd
CY2023Q4	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	5468000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1367000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	248000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	99000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	1245000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	726000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	649000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	315000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	268000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
CY2023Q1	us-gaap	Dividends Dividends	400000	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	LITIGATION<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Litigation in General</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary. The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</span></div>
CY2024Q1	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2023	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1200000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M28D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q1	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	4255000	usd
CY2023Q4	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	5468000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1367000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	248000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	99000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	1245000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	726000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	649000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	315000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	268000	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	LITIGATION<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Litigation in General</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March 31, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary. The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</span></div>
CY2024Q1	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2023	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	100000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1200000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M28D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q1	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	4255000	usd
CY2023Q4	mtex	Financeand Operating Lease Assets FinanceandOperatingLeaseAssets	4551000	usd
CY2024Q1	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	5083000	usd
CY2023Q4	mtex	Financeand Operating Lease Liabilities FinanceandOperatingLeaseLiabilities	5468000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1367000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	248000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	99000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	1245000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	327000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	726000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	649000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	315000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	268000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	90000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	55000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4255000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1307000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	326000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	154000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3929000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1153000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	55000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4255000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1307000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	326000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	154000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3929000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1153000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2024Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34100000	usd
CY2023Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34100000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	3800000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4100000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	55000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4255000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1307000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	326000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	154000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3929000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2024Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34100000	usd
CY2023Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34100000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	3800000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4100000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	55000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4255000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1307000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	326000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	154000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3929000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1153000	usd
CY2024Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	550000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2024Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34100000	usd
CY2023Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	3800000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4100000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2024Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34100000	usd
CY2023Q1	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29400000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	3800000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4100000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14500000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13700000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14500000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13700000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14500000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13700000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	14500000	usd

Files In Submission

Name	View Source	Status
0001056358-24-000042-index-headers.html	Edgar Link	pending
0001056358-24-000042-index.html	Edgar Link	pending
0001056358-24-000042.txt	Edgar Link	pending
0001056358-24-000042-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mtex-20240331.htm	Edgar Link	pending
mtex-20240331.xsd	Edgar Link	pending
mtexq1202410-qexh311.htm	Edgar Link	pending
mtexq1202410-qexh312.htm	Edgar Link	pending
mtexq1202410-qexh321.htm	Edgar Link	pending
mtexq1202410-qexh322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
mtex-20240331_def.xml	Edgar Link	unprocessable
mtex-20240331_lab.xml	Edgar Link	unprocessable
mtex-20240331_pre.xml	Edgar Link	unprocessable
mtex-20240331_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mtex-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MTEX
Mannatech Inc Stock $mtex

2024 Q2 Form 10-Q Financial Statement

#000105635824000042 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MTEX Mannatech Inc Stock $mtex

2024 Q2 Form 10-Q Financial Statement

#000105635824000042 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MTEX
Mannatech Inc Stock $mtex